Epigenetic reader domain inhibitor Mivebresib, Purity ≥98%

Cat. No.: X24-05-ZQ462

Epigenetic reader domain inhibitor Mivebresib, Purity ≥98%

Synonym: 1445993-26-9; ABBV-075; ABBV 075; ABBV075; ABBV-075; Epigenetic reader domain inhibitor

  • CAS Number: 1445993-26-9
  • Compound CID: 71600087
Product Size
2 mg; 5 mg; 10 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
Mivebresib, soluble in DMSO and insoluble in ethanol and water, disrupts the function of proteins that recognize and bind specific epigenetic marks, affecting the interpretation of epigenetic signals.
Molecular Weight
459.4678
Molecular Formula
C22H19F2N3O4S
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 79 mg/mL (171.93 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Mivebresib is employed in cancer research to understand the inhibition mechanisms of BET proteins.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.